THERAVANCE BIOPHARMA INC - NOTE 3.250%11/0

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Debt / NOTE 3.250%11/0
Total 13F principal
$0
Principal change
-$194,748,463
Total reported market value
$0
Number of holders
0
Value change
-$208,840,000
Number of sells
14

There are no holders of THERAVANCE BIOPHARMA INC - NOTE 3.250%11/0 as of Q3 2022.